• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

获得性多发性毛细血管扩张症:中国人群中的一个新实体及相关因素分析。

Telangiectasia macularis multiplex acquisita: a new entity in Chinese populations and an analysis of associated factors.

机构信息

Departments of Dermatology and Gastroenterology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.

出版信息

Int J Dermatol. 2013 Apr;52(4):426-31. doi: 10.1111/j.1365-4632.2011.05331.x. Epub 2012 Aug 22.

DOI:10.1111/j.1365-4632.2011.05331.x
PMID:22913263
Abstract

BACKGROUND

Telangiectasia macularis multiplex acquisita (TMMA) is a rarely documented entity with distinctive clinical manifestation. Most patients are middle-aged adults. It may be associated with other diseases such as hepatitis, diabetes, or cardiovascular diseases.

OBJECTIVES

To assess the clinical presentation of TMMA and its association to other systemic diseases, especially the correlation to liver disease, in Taiwan.

METHODS

We identified and retrospectively analyzed clinical criteria-matched and skin biopsy-proven patients from 2002 to 2010 at a single medical center. The clinical criteria for diagnosis of TMMA included: (i) crops of telangiectasia superimposed on erythematous macules symmetrically on bilateral upper arms, possibly extending to the forearms, shoulders, V-shaped area of the anterior chest, back or thighs; (ii) no mucosal or systemic involvement; (iii) not associated with autoimmune diseases, such as lupus erythematosus, dermatomyositis or systemic scleroderma that may induce cutaneous telangiectasia; and (iv) no ataxia or unsteady gait.

RESULTS

Twenty-five patients were enrolled in this study. The male-to-female ratio was 19:6. The age of onset was variable, mostly between the third to sixth decades. The V-shaped area of the anterior chest was commonly involved (68%), in addition to the arms (100%). Viral hepatitis was diagnosed in 56.5% of the patients (13/23); 38.9% (7/18) and 50% (9/18) of the patients had diabetes and hypertension, respectively. In addition, 64.7% of the patients (11/17) had dyslipidemia. The pathological reports of most cases showed only mild perivascular lymphocytic infiltration with or without telangiectasia.

CONCLUSIONS

TMMA should be assigned to a distinct entity with unique clinical manifestation. It has not been well recognized and mostly misdiagnosed as other diseases with telangiectasia. It is important to evaluate the complete liver function tests when TMMA is suspected.

摘要

背景

多发性局灶性毛细血管扩张症(TMMA)是一种罕见的疾病,具有独特的临床表现。大多数患者为中年成年人。它可能与其他疾病如肝炎、糖尿病或心血管疾病有关。

目的

评估 TMMA 的临床表现及其与其他系统性疾病的关联,特别是与肝病的相关性,在台湾。

方法

我们从 2002 年至 2010 年在一家医疗中心确定并回顾性分析了临床标准匹配和皮肤活检证实的患者。TMMA 的临床诊断标准包括:(i)双侧上臂对称性红斑上叠加的毛细血管扩张症,可能延伸至前臂、肩部、前胸 V 形区、背部或大腿;(ii)无黏膜或系统性受累;(iii)与可能引起皮肤毛细血管扩张的自身免疫性疾病如红斑狼疮、皮肌炎或系统性硬皮病无关;(iv)无共济失调或步态不稳。

结果

本研究共纳入 25 例患者。男女比例为 19:6。发病年龄不定,多在第三至第六个十年。前胸 V 形区常见受累(68%),其次是手臂(100%)。病毒性肝炎诊断为 56.5%的患者(13/23);38.9%(7/18)和 50%(9/18)的患者分别患有糖尿病和高血压。此外,64.7%的患者(11/17)有血脂异常。大多数病例的病理报告仅显示轻度血管周围淋巴细胞浸润,伴有或不伴有毛细血管扩张。

结论

TMMA 应归为具有独特临床表现的独特实体。它尚未得到充分认识,并且大多被误诊为其他具有毛细血管扩张的疾病。当怀疑 TMMA 时,重要的是要评估完整的肝功能检查。

相似文献

1
Telangiectasia macularis multiplex acquisita: a new entity in Chinese populations and an analysis of associated factors.获得性多发性毛细血管扩张症:中国人群中的一个新实体及相关因素分析。
Int J Dermatol. 2013 Apr;52(4):426-31. doi: 10.1111/j.1365-4632.2011.05331.x. Epub 2012 Aug 22.
2
Telangiectasia macularis multiplex acquisita accompanied by hepatitis B infection.获得性多发性斑状毛细血管扩张症伴乙型肝炎感染
Australas J Dermatol. 2017 Feb;58(1):e5-e7. doi: 10.1111/ajd.12398. Epub 2015 Oct 27.
3
Telangiectasia Macularis Multiplex Acquisita and its Potential Association with Calcium Channel Blockers: A Retrospective Study of 46 Chinese Patients.获得性多发性毛细血管扩张症及其与钙通道阻滞剂的潜在关联:46 例中国患者的回顾性研究。
Acta Derm Venereol. 2024 Oct 10;104:adv40447. doi: 10.2340/actadv.v104.40447.
4
Two case reports of telangiectasia macularis multiplex acquisita.两例获得性多发性黄斑部毛细血管扩张症病例报告。
Int J Dermatol. 2019 Nov;58(11):1334-1336. doi: 10.1111/ijd.14264. Epub 2018 Oct 12.
5
Dermoscopic features of telangiectasia macularis multiplex acquisita.获得性多发性斑状毛细血管扩张症的皮肤镜特征。
Indian J Dermatol Venereol Leprol. 2025 May-Jun;91(Supplementary 1):S82-S84. doi: 10.25259/IJDVL_762_2023.
6
Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases.持久性斑状毛细血管扩张症:三例报告
Skinmed. 2017 Jun 1;15(3):171-174. eCollection 2017.
7
Acquired bilateral telangiectasia macularis eruptiva perstans: A unique clinical feature of photodamaging rather than a subtype of cutaneous mastocytosis.获得性双侧毛细血管扩张性斑疹性持久性毛细血管扩张症:光损伤的独特临床特征,而非皮肤肥大细胞增多症的一个亚型。
J Dermatol. 2017 Nov;44(11):1276-1280. doi: 10.1111/1346-8138.13928. Epub 2017 Jun 23.
8
Telangiectasia macularis eruptiva perstans, a form of cutaneous mastocytosis, associated with malignant melanoma.持久性发疹性斑状毛细血管扩张症,一种皮肤肥大细胞增多症,与恶性黑色素瘤相关。
J Dtsch Dermatol Ges. 2009 Apr;7(4):360-2. doi: 10.1111/j.1610-0387.2008.06941.x. Epub 2008 Nov 20.
9
Unilateral facial telangiectasia macularis eruptiva perstans.单侧持久性斑状毛细血管扩张性红斑
Int J Dermatol. 1993 Feb;32(2):123-4. doi: 10.1111/j.1365-4362.1993.tb01452.x.
10
Telangiectasia macularis eruptiva perstans.持久性斑状毛细血管扩张症
Dermatol Online J. 2011 Oct 15;17(10):7.

引用本文的文献

1
Telangiectasia Macularis Multiplex Acquisita and its Potential Association with Calcium Channel Blockers: A Retrospective Study of 46 Chinese Patients.获得性多发性毛细血管扩张症及其与钙通道阻滞剂的潜在关联:46 例中国患者的回顾性研究。
Acta Derm Venereol. 2024 Oct 10;104:adv40447. doi: 10.2340/actadv.v104.40447.
2
Clinicodermoscopic and immunohistochemical observation of hepatitis B virus-associated acquired bilateral telangiectatic macules in a Chinese man.一名中国男性乙肝病毒相关性获得性双侧毛细血管扩张性斑疹的临床皮肤镜及免疫组化观察
An Bras Dermatol. 2021 Nov-Dec;96(6):791-793. doi: 10.1016/j.abd.2020.08.027. Epub 2021 Sep 27.